Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Lowering high hematocrit usually starts with treating the cause, which may include staying well hydrated, stopping smoking, addressing sleep apnea, reviewing medications like testosterone or diuretics, and in some cases therapeutic phlebotomy or medication prescribed for conditions such as polycythemia vera. Because the right approach depends on whether the elevation is from dehydration, low oxygen levels, or a bone marrow disorder, there are several important factors to consider before making changes; see below to understand more. Since a high hematocrit can thicken the blood and raise the risk of clots, it helps to know how urgent your situation is rather than guessing. A free, instant, online symptom check can help you connect your results with any symptoms you are having and clarify whether you should see a doctor now or at your next visit. Taking a few minutes to complete it gives you clearer questions to ask and a smarter path to your next step.
Last reviewed for medical accuracy: 09/12/2026
High hematocrit (HCT) means your red blood cells take up a larger share of your blood volume than normal. This can thicken your blood and raise the risk of clots, strokes or heart attacks. Understanding High Hematocrit symptoms and ways to bring your levels into a healthy range can help you feel better and protect your health.
Hematocrit is the percentage of red blood cells (RBCs) in your blood.
• Normal ranges:
– Men: about 41–52%
– Women: about 36–48%
When hematocrit climbs above these limits, blood becomes “thicker,” forcing your heart to work harder. Over time, this raises the risk of:
Symptoms often develop slowly. You might not notice anything at first. As levels rise, watch for:
If you experience chest pain, sudden weakness, slurred speech or vision loss, seek emergency care—these could signal a blood clot.
• Drink plain water throughout the day.
• Aim for about 2–3 liters daily (adjust for size, climate, activity).
• Limit excessive caffeine or alcohol, which can dehydrate you.
• Smoking cessation reduces carbon monoxide exposure and normalizes RBC production.
• Seek support: counseling, nicotine replacement, or prescription aids.
• Aim for 30 minutes most days of moderate activity (walking, cycling, swimming).
• Avoid extreme endurance events without medical supervision, as they can temporarily spike hematocrit.
• Sleep apnea: Using CPAP can improve oxygen levels and lower RBC overproduction.
• Lung or heart disease: Follow prescribed treatments to optimize oxygen delivery.
• Removal of a pint of blood under medical supervision can quickly reduce hematocrit.
• Frequency varies—every few weeks to months—depending on your levels and cause.
• Hydroxyurea: Lowers RBC production in disorders like polycythemia vera.
• Aspirin: Low-dose may reduce clot risk (only under doctor’s advice).
• Interferon-alpha or other agents: Used in specific blood disorders.
• Avoid unnecessary iron supplements unless you’re deficient.
• Focus on an anti-inflammatory diet rich in fruits, vegetables, whole grains and lean proteins.
• Stay balanced—extreme diets or excessive red-meat intake are not recommended.
• If you live at high altitude and develop high hematocrit without other causes, discuss relocation or supplemental oxygen options.
Even mild increases in hematocrit warrant follow-up. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance. If you notice any of these, speak to your doctor right away:
These could be signs of a blood clot or other serious complication.
Lowering high hematocrit often brings quick relief from symptoms like headaches and dizziness. Long-term success depends on:
By partnering with your healthcare provider and watching for High Hematocrit symptoms, you can reduce risks and return to your normal routine.
Important: This information is not a substitute for medical advice. If you suspect anything life-threatening or serious, please speak to a doctor immediately.
Stay proactive and informed—your health is worth it.
(References)
* Messmer K. Hemodilution. Surg Clin North Am. 1975 Jun;55(3):659-78. doi: 10.1016/s0039-6109(16)40641-9. PMID: 1135750.
* Schussman LC, Wright ST. Neonatal polycythemia. Am Fam Physician. 1984 Feb;29(2):111-7. PMID: 6702518.
* Krishnan L, Rahim A. Neonatal polycythemia. Indian J Pediatr. 1997 Jul-Aug;64(4):541-6. doi: 10.1007/BF02737765. PMID: 10771885.
* Nigg C, Naumann UK, Käser L. [Thrombocytosis]. Praxis (Bern 1994). 2008 Apr 2;97(7):343-9; quiz 350-1. doi: 10.1024/1661-8157.97.7.343. PMID: 18548812.
* Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T, CYTO-PV Collaborative Group. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8. PMID: 23216616.
* Spivak JL. Polycythemia Vera. Curr Treat Options Oncol. 2018 Mar 7;19(2):12. doi: 10.1007/s11864-018-0529-x. Epub 2018 Mar 7. PMID: 29516275.
* Van Buren NL, Hove AJ, French TA, Gorlin JB. Therapeutic Phlebotomy for Testosterone-Induced Polycythemia. Am J Clin Pathol. 2020 Jun 8;154(1):33-37. doi: 10.1093/ajcp/aqaa019. PMID: 32134468.
* White J, Petrella F, Ory J. Testosterone therapy and secondary erythrocytosis. Int J Impot Res. 2022 Nov;34(7):693-697. doi: 10.1038/s41443-021-00509-5. Epub 2022 Jan 6. PMID: 34987178.
* Kremyanskaya M, Kuykendall AT, Pemmaraju N, Ritchie EK, Gotlib J, Gerds A, Palmer J, Pettit K, Nath UK, Yacoub A, Molina A, Saks SR, Modi NB, Valone FH, Khanna S, Gupta S, Verstovsek S, Ginzburg YZ, Hoffman R, REVIVE Trial Investigators. Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera. N Engl J Med. 2024 Feb 22;390(8):723-735. doi: 10.1056/NEJMoa2308809. PMID: 38381675.
* Pemmaraju N, Yu J, Vasudevan A, Qureshi H, Braunstein E, Chojecki A. Treatment patterns and blood count control in 10,112 patients with polycythemia vera. Expert Rev Hematol. 2025 Jul;18(7):529-536. doi: 10.1080/17474086.2025.2520316. Epub 2025 Jun 26. PMID: 40512071.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.